Celltrion Pharm, Inc. (068760.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap2.52T
Enterprise Value2.63T
P/E Ratio36
PEG Ratio0.98
Price/Sales Ratio2.96
Price/Book Ratio3.91
Enterprise/Revenue3.14
Enterprise/EBITDA21.62

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.08
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.11

Income Statement

Revenue536.4B
Revenue/Share13,773.71
Gross Profit160.98B
EBITDA78.34B
Net Income38.75B
Diluted EPS891.88

Balance Sheet

Total Cash123.82B
Total Cash/Share2,834.39
Total Debt160.15B
Total Debt/Equity0.36
Current Ratio1.71
Book Value Per Share10,282.95

Price History

52-Week Change-37.79
52-Week High78,300
52-Week Low35,600
Moving Average 50 Days38,950
Moving Average 200 Days49,389

Statistics

Average Volume75,357
Shares Outstanding44.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate200
Trailing Annual Dividend Yield0.5
Payout Ratio0.18
Last Split Factor51:50
Last Split DateDecember 29, 2025
AD